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Advanced Research Center for Beam Science
- Structural Molecular Biology -
http://www.scl.kyoto-u.ac.jp/˜hata/index.html 
The research activities in this laboratory are performed for X-ray structural analyses of biological macromolecules and 
the investigation of the electronic state in materials as follows: The main subjects of the biomacromolecular crystallogra-
phy are crystallographic studies on the reaction mechanism of enzymes, the relationship between the multiform confor-
mation and the functional variety of proteins, and the mechanism of thermostabilization of proteins.  In the investigation 
of the chemical state in materials, the characteristics of the chemical bonding in the atom and molecules are investigated 
in detail using a newly developed X-ray spectromator with a high-resolution in order to elucidate the property of materi-
als. The theoretical analysis of the electronic states with DV-Xα and WIEN2k, and the development of new typed X-ray 
spectrometer with ultra high-resolution have also been carried out.
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Top ics
Crystal Structure of the Inhibitor IC in 
Complex with Carboxypeptidase Y
The proteinous proteinase inhibitor IC, which exists 
in the cytoplasm of the yeast Saccharomyces cerevisiae, 
specifi cally forms the 1:1 complex with and then inhibits 
carboxypeptidase Y (CPY) which is the vacuolar serine 
carboxypeptidase. The inhibitor belongs to the phosphati-
dylethanolamine-binding protein (PEBP) family. In order 
to reveal the inhibitory mode of IC against CPY, we deter-
mined the 2.7Å crystal structure of the IC-CPY complex by 
the MR method of X-ray crystallography. This represents 
the first structure of a natural serine carboxypeptidase 
inhibitor complexed with the cognate proteinase and also 
that of a PEBP member complexed with its macromolecu-
lar binding partner.
The final structure model of the IC-CPY complex 
contains 204 amino acid residues of IC consisting of 219 
amino acid residues. Residues Lys73-Ala78 and Glu122-
Ala130 of IC are excluded in the model because they are 
invisible in the electron density map. The overall structure 
of the complex is a compact ellipsoidal structure (Fig1). 
The structure of the complex contains two binding sites of 
IC toward CPY: the N-terminal inhibitory reactive site and 
the secondary CPY-binding site, which interact with the S1 
substrate-binding site of CPY and the hydrophobic surface 
fl anked by the active site of the enzyme, respectively. The 
structure of IC in complex with CPY consists of one major 
β-type domain and an N-terminal helical segment (Fig2). 
The N-terminal segment is the helical region 1 (HR1), 
which is formed by one 310-helix (η1) and two α-helices 
(α1-2) and is in direct contact with CPY. The major do-
main is made up of three segments: the strand-rich region 
1 (SR1), strand-rich region 2 (SR2), and helical region 2 
(HR2). IC is also revealed to have the ligand-binding site, 
which is conserved among PEBPs and the putative binding 
site of the polar head group of phospholipid.
To further clarify the proteinase-inhibition mode of IC 
indicated by the three-dimensional structure of the com-
plex, we analysed the biochemical properties of various 
IC mutants: the N-terminal unacetylated form (unaIC), an 
N-terminal modifi ed form with the substitution of Gly for 
the acetyl group (gIC), the N-terminal seven-residues de-
leted form (d1-7IC), and the unacetylated and C-terminal 
deleted form (d217-219IC). The inhibition of anilidase 
activity of CPY by the native and mutant forms of IC 
showed that the inhibitor constants, Ki, for unaIC, gIC, and 
d217-219IC were increased by 590-, 180-, and 550-fold, 
respectively, over that of the native and that the N-terminal 
deleted mutant (d1-7IC) had no detectable inhibitory ac-
tivities against CPY (Fig3). These results indicate that the 
N-terminal acetyl group has optimal properties for the ef-
fi cient inactivation of CPY and that the N-terminal seven 
residues of IC, designated as the N-terminal inhibitory re-
active site, are absolutely essential for the inhibitory activ-
ity of IC in solution.
Figure 1. Ribbon drawing of the IC-CPY complex at 2.7 Å resolution. IC 
and CPY are shown in blue and green, respectively. Sulfate ions are rep-
resented by red spheres.
Figure 2. A topology diagram of the secondary-structure elements in IC. 
β-Strands (β1-9) are represented by arrows, and α-helices (α1-3) and 
310-helices (η1-4) by rectangles.
Figure 3. Stoichiometry of CPY inhibition by IC and its mutants.
